Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases-Reference-Cited by-同舟云学术

Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases

Published:2024-07-24 Issue:8 Volume:2 Page:
ISSN:2755-1520
Container-title:JCEM Case Reports
language:en
Short-container-title:

Author:

Hamidi Sarah¹^ORCID,Mahvash Armeen²^ORCID,Hu Mimi I¹^ORCID

Affiliation:

1. Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer , Houston, TX 77030 , USA

2. Department of Interventional Radiology, The University of Texas MD Anderson Cancer , Houston, TX 77030 , USA

Abstract

Abstract Medullary thyroid carcinoma (MTC) can often have an indolent course despite distant metastatic disease. Additionally, given that metastatic MTC is incurable and systemic therapies have non-negligeable toxicities, localized treatments are often favored in presence of oligo-progressive disease. Transarterial radioembolization (TARE) with yttrium-90 (Y90) has emerged as a safe and efficacious treatment for nonresectable primary and metastatic liver tumors, yet data supporting its use in metastatic MTC are limited. We present the case of a patient with hereditary MTC and large bilobar liver metastases who demonstrated tumor response and resolution of their paraneoplastic diarrhea following TARE with Y90 microspheres.

Publisher

The Endocrine Society

Link

https://academic.oup.com/jcemcr/article-pdf/2/8/luae103/58812124/luae103.pdf

Reference26 articles.

1. Metastatic medullary thyroid carcinoma: a new way forward;Angelousi;Endocr Relat Cancer,2022

2. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma;Wells;Thyroid,2015

3. Sporadic medullary thyroid carcinoma: towards a precision medicine;Matrone;Front Endocrinol (Lausanne),2022

4. Diarrhea as an initial presentation in patients with medullary thyroid cancer: delaying the diagnosis;Shakir;Case Rep Gastroenterol,2020

5. Medullary thyroid cancer: updates and challenges;Gild;Endocr Rev,2023